Recent Research Analysts’ Ratings Updates for Aflac (AFL)

Several brokerages have updated their recommendations and price targets on shares of Aflac (NYSE: AFL) in the last few weeks:

• 7/23/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
• 7/22/2026 – Aflac had its “hold” rating reaffirmed by TD Cowen. They now have a $110.00 price target on the stock, up from $101.00.
• 7/21/2026 – Aflac had its price target raised by JPMorgan Chase & Co. from $108.00 to $117.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – Aflac had its price target raised by Keefe, Bruyette & Woods from $115.00 to $120.00. They now have a “market perform” rating on the stock.
• 7/10/2026 – Aflac had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $108.00 price target on the stock, up from $100.00.
• 7/9/2026 – Aflac was given a new $112.00 price target by Mizuho.
• 7/9/2026 – Aflac had its price target raised by Wells Fargo & Company from $111.00 to $120.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – Aflac had its “neutral” rating reaffirmed by UBS Group AG. They now have a $124.00 price target on the stock, up from $114.00.
• 7/7/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 7/7/2026 – Aflac had its price target lowered by Barclays PLC from $99.00 to $98.00. They now have an “underweight” rating on the stock.
• 6/15/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.

Insider Activity

In other news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.12, for a total transaction of $7,441,560.00. Following the completion of the transaction, the insider owned 51,169,435 shares in the company, valued at approximately $6,044,133,662.20. This represents a 0.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 744,916 shares of company stock worth $87,118,632 over the last three months. Insiders own 0.80% of the company’s stock.

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.